News
Media
Women in science and business challenges and perspectives
BIO International Convention 2024
The academic enterprise : a pillar of the healthcare innovation ecosystem
$21 M to combat antimicrobial drug resistance
Restoring the Glory of Canada’s Life Sciences Sector
IRICoR, moteur des sciences de la vie au Québec
How can Quebec become a global leader in Life Science Innovation?
IRICoR will attend the AUTM Annual Meeting
On the Path to Inclusivity, Even Small Steps Keep Us Moving Forward
IRICoR to attend BIO-Europe 2023
Great partnerships create great opportunities!
BIO International Convention 2023
ELIZABETH DOUVILLE appointed president – CEO of IRICoR
Ipsen, UdeM and IRICoR broaden existing oncology partnership (…)
New strategic investment of IRICoR in RejuvenRx Spin-off
Gwenaëlle Gavory joins the IRICoR team
Intellectual property management: a formidable marketing lever for anticancer therapies
Dr Mario Callejo, new VP – Scientific Operations at IRICoR
IRICoR will attend the LES 2022 Annual Meeting
Ms Nioucha Rodrigue joins the IRICoR team
Claude Larose, new VP – Business Development at IRICoR
IRICoR will attend the AUTM Canadian Region Meeting
A new agreement for an international public-private research collaboration in drug discovery
Identification of ten novel tumor-specific antigens immunogenic for T cells
